Clinical Trial Update: Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant

View source ↗

Summary

A completed clinical trial from Vanderbilt University evaluating immunoregulatory cells to prevent or mitigate graft-versus-host disease in hematopoietic stem c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Snippet

Sponsor: Vanderbilt University | Conditions: Hematopoietic Stem Cell Transplantation, Graft vs Host Disease | Status: COMPLETED